Europe faces a stubborn public health gap that threatens to derail its goal of eliminating viral hepatitis by the end of the decade, according to new data published by the European Centre for Disease Prevention and Control (ECDC). While childhood vaccination has successfully pushed hepatitis B prevalence to near-zero levels among children under five across … Read more
Most U.S. adults remain uncertain about which vaccines are recommended during pregnancy, according to a July 2026 survey by the Annenberg Public Policy Center (APPC) of the University of Pennsylvania. While awareness of seasonal flu shots is highest, fewer than one-third of Americans correctly identify the CDC’s recommendations for Tdap, RSV, or hepatitis B vaccines, … Read more
Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer death, with patient outcomes hindered by late diagnosis and scarce early biomarkers. According to a 2026 review in the journal Gene Expression, advancements in multi-omics and liquid biopsy are shifting the clinical landscape by enabling more precise prognostic tracking and personalized immunotherapy selection, though … Read more
New Research Challenges Traditional Management of Immune-Tolerant Chronic Hepatitis B For patients diagnosed with chronic hepatitis B in the immune-tolerant (IT) phase, clinical management has historically been characterized by monitoring rather than active intervention. However, new findings published in the Journal of Clinical and Translational Hepatology suggest that a more proactive approach involving pegylated interferon … Read more
The Shift Toward Long-Term Safety in Hepatitis B Care For years, managing chronic hepatitis B (CHB) has been a balancing act between suppressing the virus and managing the side effects of medication. Recent long-term data is now highlighting a significant trend: the transition toward treatments that prioritize not just viral suppression, but the preservation of … Read more
The Looming Liver Cancer Crisis: A Global Shift in Risk Factors Liver cancer remains a significant global health threat, ranking as the third leading cause of cancer-related deaths worldwide. In 2022 alone, nearly 870,000 new cases were reported, with hepatocellular carcinoma accounting for almost 80% of these. A concerning trend is emerging: even as progress … Read more
The Looming Shadow of Resurgent Diseases: Beyond Measles The recent surge in measles cases across the United States – with over 1,671 confirmed cases reported in 2026 alone – serves as a stark warning. But measles may not be the only once-conquered foe poised for a comeback. A concerning trend is emerging with declining vaccination … Read more
Shifting Sands: The Future of Childhood Vaccination in the US A recent announcement from the Department of Health and Human Services (HHS) signaling a reduction in recommended vaccines for children has ignited a national debate. The move, shrinking the standard schedule from 17 to 11 vaccines, represents a significant departure from decades of established practice … Read more
Malaysia’s Stand on Hepatitis B: A Blueprint for Global Pediatric Health? The recent reaffirmation by the Malaysian Paediatric Association (MPA) of its universal Hepatitis B (HepB) birth dose policy, in contrast to evolving US guidance, isn’t simply a local health decision. It’s a potential bellwether for how nations navigate complex public health strategies in the … Read more
The Shifting Sands of Newborn Vaccination: What the CDC’s Hepatitis B Decision Means for the Future The U.S. Centers for Disease Control and Prevention’s recent decision to move away from universal hepatitis B vaccination for newborns marks a pivotal moment in preventative healthcare. It’s a shift driven by a newly appointed advisory committee, and one … Read more